Related Experiment Videos
Association between interleukin-6 gene polymorphisms and bone mineral density: a meta-analysis
Zhao Wang1, Yonghong Yang, Minjuan He
11 Department of Orthopedics, The 117th Hospital of PLA , Hangzhou, China .
Genetic Testing and Molecular Biomarkers
|September 24, 2013
Summary
Interleukin-6 (IL-6) gene polymorphisms, specifically -634C/G, show a significant association with lower bone mineral density (BMD) at multiple skeletal sites. Further research is needed to explore gene-environment interactions affecting BMD.
Area of Science:
- Genetics
- Bone Metabolism
- Biochemistry
Background:
- Interleukin-6 (IL-6) gene polymorphisms have been studied for their association with bone mineral density (BMD).
- Previous research findings on this relationship are conflicting.
- A meta-analysis was conducted to clarify the association between IL-6 gene polymorphisms and BMD.
Purpose of the Study:
- To precisely assess the relationship between IL-6 gene polymorphisms (-634C/G and -174G/C) and bone mineral density (BMD).
- To synthesize existing evidence through a meta-analysis.
Main Methods:
- A systematic literature search was performed across major databases (PubMed, Embase, CBM, Wanfang, CNKI) up to March 2013.
- Weighted mean difference (WMD) and 95% confidence intervals (95% CI) were calculated.
- Fixed-effects or random-effects models were employed for analysis.
Main Results:
- The meta-analysis included 16 studies with 11,957 subjects.
- -634C/G polymorphism (GG vs. CC+CG) was significantly associated with lower BMD at the femoral neck, lumbar spine, and whole body.
- Asian populations with the -634GG genotype showed significantly lower BMD. The -174G/C polymorphism also showed associations with BMD at specific skeletal sites.
- No significant publication bias was detected for either polymorphism.
Conclusions:
- IL-6 gene polymorphisms (-634C/G and -174G/C) have modest effects on BMD.
- Larger, well-designed studies are necessary to investigate gene-gene and gene-environment interactions influencing BMD in diverse populations.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Role of Vitamins in Maintaining Bone Health
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...